Al-Razi Medical Company (TADAWUL:9572)

Al-Razi Medical Company Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 11, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	45	90	91	-	-
Market Cap Growth	-50.83%	-1.34%	-	-	-
Enterprise Value	58	98	97	-	-
Last Close Price	29.50	59.00	59.80	-	-
PE Ratio	159.17	509.93	132.51	-	-
PS Ratio	0.70	1.46	1.48	-	-
PB Ratio	1.97	3.96	4.06	-	-
P/TBV Ratio	2.00	4.03	4.15	-	-
P/FCF Ratio	55.20	81.55	91.19	-	-
P/OCF Ratio	11.40	18.09	15.73	-	-
EV/Sales Ratio	0.90	1.60	1.59	-	-
EV/EBITDA Ratio	11.26	36.62	32.66	-	-
EV/EBIT Ratio	40.73	94.35	62.66	-	-
EV/FCF Ratio	70.94	89.31	97.71	-	-
Debt / Equity Ratio	0.58	0.38	0.48	0.32	0.27
Debt / EBITDA Ratio	2.56	1.78	2.04	1.45	1.49
Debt / FCF Ratio	16.11	7.86	10.73	-	-
Net Debt / Equity Ratio	0.56	0.34	0.44	0.26	-0.05
Net Debt / EBITDA Ratio	4.08	2.88	3.30	1.68	-0.36
Net Debt / FCF Ratio	15.75	7.03	9.87	-9.51	0.43
Asset Turnover	1.34	1.42	1.39	1.26	-
Inventory Turnover	2.21	2.23	1.98	1.84	-
Quick Ratio	0.29	0.27	0.14	0.19	0.89
Current Ratio	1.56	1.92	1.79	2.07	2.61
Return on Equity (ROE)	1.25%	0.78%	2.99%	8.43%	-
Return on Assets (ROA)	1.85%	1.51%	2.20%	3.88%	-
Return on Invested Capital (ROIC)	1.71%	1.10%	3.17%	8.12%	8.99%
Return on Capital Employed (ROCE)	4.20%	3.50%	5.00%	8.60%	8.20%
Earnings Yield	0.63%	0.20%	0.76%	-	-
FCF Yield	1.81%	1.23%	1.10%	-	-
Dividend Yield	5.38%	-	2.65%	-	-
Payout Ratio	-	-	351.72%	93.81%	-
Total Shareholder Return	5.47%	-	2.65%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.